MJBizDaily
The best thing to happen to New York cannabis retailers
Featured
Latest Posts
New Frontier Data paying $10 million for cannabis research firm
New Frontier Data, a privately owned data analytics firm in Washington DC that focuses on the cannabis industry, plans to pay roughly $10 million for a Denver-area company in the…
News October 9Analysis: German sales of insured medical cannabis soar in second quarter
Sales of medical cannabis covered by insurance continue to increase in Germany, reaching new highs in the second quarter, according to newly released data. The steady growth in sales in the world’s…
News October 9Will Illinois change the social equity landscape for the marijuana industry?
Illinois is set to open recreational cannabis dispensaries Jan. 1 after becoming the first state in the nation to officially legalize adult-use marijuana via its Legislature in June – and the…
News October 9Even without reform, banks increasingly serving marijuana industry
The cannabis industry experienced a 62% year-over-year jump in banking options in the federal government’s most recent quarter. The number of banks and credit unions actively serving the marijuana industry…
News October 8New Mexico requires cannabis vape products to include health warning
New Mexico regulators are requiring marijuana vape products to be labeled with a warning in the wake of the nationwide vaping health crisis. The health department isn’t banning any products…
News October 8Cannabis comp tables as of Oct. 7, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
News October 8Citing ‘consistent failure,’ Aleafia nixes cannabis supply deal with Aphria
Toronto marijuana company Aleafia Health intends to cancel a supply agreement with Aphria, citing a “consistent failure” to meet its obligations to provide cannabis. The industry has grappled with supply…
News October 8MedMen terminates PharmaCann acquisition, CFO amid rising financial risk for company
This morning MedMen Enterprises (CSE: MMEN) announced they are ending their agreement to acquire PharmaCann, terminating their CFO Michael Kramer and pushing out their EBITDA break-even to end of calendar…
News October 8MedMen and PharmaCann terminate $682 million cannabis merger; MedMen CFO ousted
MedMen, a Los Angeles-based multistate marijuana operator, announced that its blockbuster acquisition of PharmaCann has been scuttled and that the company will focus on beefing up its retail operations in…
News October 8












